The ALEX RS is a bilateral upper-limb exoskeleton designed for post-stroke rehabilitation, covering 92% of the human arm's natural range of motion and is CE certified as a Class IIa medical device.
The body of the robotic fingers is built from polyglycerol sebacate, a synthetic elastomer made from glycerol and sebacic acid. Glycerol is a byproduct of biodiesel production while sebacic acid is derived from castor oil, and both of them are plant-based. Polyglycerol sebacate is safe since it is already used in medical implants because the body can absorb it without a toxic response.
The business itself tells a different story. Stryker just crossed $25 billion in annual revenue for the first time, posting 11.4% revenue growth in Q4 2025 and beating earnings estimates in all four quarters of 2025. Adjusted operating margins expanded at least 100 basis points for the second consecutive year. Free cash flow grew to $4.28 billion, up nearly 23% year over year. These are not the numbers of a company in distress.
"This is a kind of a classic example of a prepared mind meets opportunity," Kashani said. "Robots that are moving among people is the broader opportunity for us. Once you solve the problem, which is how to get robots to seamlessly move among people as autonomous machines, then you can bring it to a lot of other environments. We knew that we wanted to do this someday."
An exoskeleton is a relatively new class of wearable device designed to enhance, support, or assist human movement, strength, posture, or even physical activity. The main piece goes around your waist like a belt, and from it, a pair of hinged, mechanized splints extend down over the hips to strap onto each thigh, where they provide some robotic assistance to normal movements like walking, running, or squatting.
As the Magerstadt Professor of Cardiovascular Epidemiology, Khan studies the epidemiology of risk for heart failure. Using population-based cohorts and large electronic health record data analyses, she performs mechanistic studies that may enhance risk prediction and identify novel therapeutic agents for the prevention and treatment of cardiovascular disease. Khan and her team have developed a tool to predict risk and prevent cardiovascular disease such as heart failure, stroke, arrhythmia, coronary artery disease and many other conditions.
In 2024, the NHS began testing whether flying drones could do a better job than couriers shuttling blood samples between labs in Guy's and St Thomas' hospitals. Instead of weaving through traffic, the drones simply lifted off, crossed central London, and landed minutes later. Delivery times dropped to barely a couple of minutes, reliability shot up thanks to a lack of roadworks in the sky, and the service turned out to be cheaper too. Since then, more than 6,000 samples have been transported by air.
The reported wiper attack ... may represent a similar dynamic, an early signal of activity that could expand beyond a single target. Organizations need to assume that attackers will gain a foothold and focus on proactively shutting down the attack paths adversaries rely on to escalate privileges, move laterally and expand their impact.
Medtronic ( NYSE: MDT) delivered its strongest enterprise revenue growth in 10 quarters, posting 8.7% reported growth (6.0% organic) for Q3 fiscal 2026. Cardiac Ablation Drives Outperformance The Cardiovascular Portfolio led the quarter with 13.8% reported growth, powered by an exceptional 80% surge in Cardiac Ablation Solutions. U.S. cardiac ablation revenue exploded 137%, driven by the company's pulsed field ablation (PFA) portfolio. Cardiac Rhythm & Heart Failure revenue reached $1.86 billion, up 17%, while Diabetes posted 8.3% organic growth to $796 million.
There's something quietly radical about designing for pain. Not the dramatic, cinematic kind, but the daily grind of chronic discomfort that shapes how millions of people move through their lives. That's exactly what Madhav Binu, Kriti V, and Himvall Sindhu set out to tackle with Revive, a home-based rehabilitation device for knee osteoarthritis patients. The numbers tell a sobering story. Forty percent of India's elderly population lives with knee osteoarthritis, a condition that doesn't just hurt.
A study led by Stanford Medicine researchers has found that an injection blocking a protein linked to aging can reverse the natural loss of knee cartilage in older mice. The same treatment also stopped arthritis from developing after knee injuries that resemble ACL tears, which are common among athletes and recreational exercisers. Researchers note that an oral version of the treatment is already being tested in clinical trials aimed at treating age-related muscle weakness.
Bracesys sidesteps all these limitations with an adjustable framework of segmented units, articulating connectors, and tension dials. The entire system weighs just 150 grams and folds flat into an envelope, yet provides rigid support comparable to traditional casts. More remarkably, clinicians can customize it to each patient's anatomy in real time, adjusting the fit as swelling decreases and healing progresses.
